Eric Lawitz - Researcher Profile | RDL Research Database

Publications

2 shown

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi , Vlad Ratziu , Rohit Loomba +97 more

2019 The Lancet 1142 citations

Changes in liver enzymes and cardiometabolic markers in individuals with obesity and metabolic-dysfunction-associated steatohepatitis treated with semaglutide

Husam Albarmawi , Firas Dabbous , Abdalla Aly +5 more

In patients with MASH and either overweight or obesity, semaglutide was associated with a clinically and statistically significant reduction in ALT after 6 months of continuous ...

2025 Current Medical Research and Opinion 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 2
Citations: 1,142
Institution: Texas Liver Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-4234-224X

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.